BYONG (CHRISTOPHER) KIM

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

LIPELLA PHARMACEUTICALS INC.

Filing Date Source Excerpt
2023-10-10 Mr. Kim holds a B.S. in Biology from the University of California at Irvine, a PhD in Developmental Biology from the University of Texas at MD Anderson, and an MBA from Carnegie Mellon University.
2024-08-12 Mr. Kim holds a B.S. in Biology from the University of California at Irvine, a PhD in Developmental Biology from the University of Texas at MD Anderson, and an MBA from Carnegie Mellon University.
2024-11-12 Byong (Christopher) Kim beneficially owns shares and holds stock options exercisable for shares of Common Stock, but no mention of software or technical background.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-25